Ace-Inhibitors and Cardioprotection Open Issues and Future Solutions

Chairpeople:

Giuseppe Mancia¹

Speakers:

Krzysztof Narkiewicz,² Athanasios J. Manolis,³ Claudio Borghi⁴

1. Department of Internal Medicine and Cardiovascular Prevention, S. Gerardo Hospital, Milan, Italy
2. Medical University of Gdansk, Poland
3. Director, Cardiology Department, Asklepeion Hospital, Athens, Greece
4. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

Disclosure:

Speakers participating in this symposium received honorarium from Menarini.

Acknowledgements:

Writing assistance provided by Trilogy Writing and Consulting Ltd.

Support:

The publication of this article was funded by Menarini. The views and opinions expressed are those of the authors and not necessarily of Menarini.

Citation:

EMJ Cardiol. 2013;1[1]:36-51. DOI/10.33590/emjcardiol/10313347. https://doi.org/10.33590/emjcardiol/10313347.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.